Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
4.620
+0.020 (0.43%)
At close: Aug 28, 2026, 4:00 PM EDT
4.800
+0.180 (3.90%)
After-hours: Aug 28, 2026, 7:34 PM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $62.42 million as of August 28, 2026. Its market cap has increased by 269.58% in one year.
Market Cap
62.42M
Enterprise Value
52.09M
1-Year Change
269.58%
Ranking
Category
Stock Price
$4.62
ChartMarket Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $62.42M, an increase of 68.17%. That is a compound annual growth rate of 7.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 62.42M | 427.49% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rein Therapeutics | 65.74M |
| MindWalk Holdings | 65.31M |
| PMV Pharmaceuticals | 65.22M |
| INmune Bio | 64.67M |
| Boundless Bio | 64.37M |
| Alps Group | 64.05M |
| BioStem Technologies | 63.01M |
| Serina Therapeutics | 62.49M |